Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules

Frontiers in Genetics

Genetics

Faizah Alotaibi¹ 

[1] null;

关键词: exosomal miRNA;    extracellular vesicles (EVs);    cancer;    small non-coding RNAs (sncRNAs);    biomarker;    clinical implication;    liquid bioposy;    immune checkpoint molecules;   

DOI  :  10.3389/fgene.2023.1052731

 received in 2022-09-24, accepted in 2023-02-07,  发布年份 2023

来源: Frontiers

【 摘 要 】

Exosomes are small extracellular vesicles with a lipid bilayer structure secreted from different cell types which can be found in various body fluids including blood, pleural fluid, saliva and urine. They carry different biomolecules including proteins, metabolites, and amino acids such as microRNAs which are small non-coding RNAs that regulate gene expression and promote cell-to-cell communication. One main function of the exosomal miRNAs (exomiRs) is their role in cancer pathogenesis. Alternation in exomiRs expression could indicate disease progression and can regulate cancer growth and facilitate drug response/resistance. It can also influence the tumour microenvironment by controlling important signaling that regulating immune checkpoint molecules leading to activation of T cell anti-tumour immunity. Therefore, they can be used as potential novel cancer biomarkers and innovative immunotherapeutic agents. This review highlights the use of exomiRs as potential reliable biomarkers for cancer diagnosis, treatment response and metastasis. Finally, discuses their potential as immunotherapeutic agents to regulate immune checkpoint molecules and promote T cell anti-tumour immunity.

【 授权许可】

Unknown   
Copyright © 2023 Alotaibi.